Correlation Between Mechema Chemicals and Orient Europharma

Can any of the company-specific risk be diversified away by investing in both Mechema Chemicals and Orient Europharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mechema Chemicals and Orient Europharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mechema Chemicals Int and Orient Europharma Co, you can compare the effects of market volatilities on Mechema Chemicals and Orient Europharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mechema Chemicals with a short position of Orient Europharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mechema Chemicals and Orient Europharma.

Diversification Opportunities for Mechema Chemicals and Orient Europharma

0.22

Correlation Coefficient

Mechema Chemicals  Orient Europharma

Modest diversification

The 3 months correlation between Mechema and Orient is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Mechema Chemicals Int and Orient Europharma Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orient Europharma and Mechema Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mechema Chemicals Int are associated (or correlated) with Orient Europharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orient Europharma has no effect on the direction of Mechema Chemicals i.e., Mechema Chemicals and Orient Europharma go up and down completely randomly.

Pair Corralation between Mechema Chemicals and Orient Europharma

Assuming the 90 days trading horizon Mechema Chemicals Int is expected to under-perform the Orient Europharma. But the stock apears to be less risky and, when comparing its historical volatility, Mechema Chemicals Int is 1.04 times less risky than Orient Europharma. The stock trades about -0.06 of its potential returns per unit of risk. The Orient Europharma Co is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  4,755  in Orient Europharma Co on December 24, 2024 and sell it today you would earn a total of  315.00  from holding Orient Europharma Co or generate 6.62% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Mechema Chemicals Int  vs.  Orient Europharma Co

Mechema Chemicals Int

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mechema Chemicals Int has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Orient Europharma

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Orient Europharma Co are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Orient Europharma may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Mechema Chemicals and Orient Europharma

The main advantage of trading using opposite Mechema Chemicals and Orient Europharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mechema Chemicals position performs unexpectedly, Orient Europharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orient Europharma will offset losses from the drop in Orient Europharma's long position.

The idea behind Mechema Chemicals Int and Orient Europharma Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.